7 CFTR Articles You Can’t Miss

admin avatar

by admin |

Share this article:

Share article via email

1. Partnership to Promote Next-Generation Diagnostic Test for CF

Read about a partnership to simplify the adoption of next-generation DNA sequencing for routine diagnostic laboratories. According to the terms of the agreement, Sophia Genetics will use its advanced analytical platform, Sophia DDM, to support Devyser’s NGS diagnostic kits for cystic fibrosis and hereditary breast cancer.

Learn 7 facts about CFTR and cystic fibrosis genetics.

2. CFTR Abundant in Gut, Possible Reason for Intestinal Problems in CF Patients

shutterstock_424899703

The cystic fibrosis transmembrane conductance regulator (CFTR), a key protein that is defective in people with cystic fibrosis, is abundant in the gastrointestinal tract of people and may be a reason why CF patients are troubled by gastrointestinal problems, a recent collaborative study reported. Read the article here.

Learn 7 facts about CFTR and cystic fibrosis genetics.

3. Data on Inhaled CF Therapy in Clinical Testing To Be Presented at NACFC 2016

Learn 7 facts about CFTR and cystic fibrosis genetics.

4. Vertex Enrolling Patients with CF in Three, Phase 3 Studies of VX-661 and Kalydeco Combo Therapy

CF clinical trial update

Vertex Pharmaceuticals recently gave an update on its Phase 3 development program, which consists of four studies, on the investigational compound VX-661 in combination with Kalydeco (ivacaftor) as a treatment of patients with cystic fibrosis. Read the article here.

Learn 7 facts about CFTR and cystic fibrosis genetics.

5. CF Patients Being Recruited for Phase 1 Study of Oral CFTR Amplifier

CF clinical study

Proteostasis Therapeutics announced the enrollement of cystic fibrosis patients and healthy adults in two Phase 1 clinical trials evaluating its lead drug candidate PTI-428, an oral amplifier of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Learn 7 facts about CFTR and cystic fibrosis genetics.

6. Full Gene Sequencing Might Detect CF Mutations in Babies of Any Ethnicity, Study Says

Babies with a mutation known to cause cystic fibrosis and a second mutation called the 5T allele should be screened for additional mutations to predict their risk of developing CF later in life, according to a study. Read about it here.

Learn 7 facts about CFTR and cystic fibrosis genetics.

7. CF Foundation Research Conference Gathers Genetic Experts From Many Fields

Cystic Fibrosis Foundation's research conference.

The Cystic Fibrosis Foundation hosted more than 100 researchers from various fields at its “New Technologies Advancing Toward a One-time Cure” conference last June to debate how new research and treatments for genetic diseases across the  board could lead to a cure for cystic fibrosis. Read about it here.

Learn 7 facts about CFTR and cystic fibrosis genetics.

Cystic Fibrosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.


Featured Column

The Benefits of Being Sick

A banner for Lara's column, depicting a car on a road trip winding through a forest.
As columnist Lara Govendo reflects on her journey through CF and transplant, she realizes there are a surprising number of benefits.

Read the Column


Your CF Community


Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.